Increased nm23-H1 and nm23-H2 Messenger RNA Expression and Absence of Mutations in Colon Carcinomas of Low and High Metastatic Potential

Background The murine nm23 gene suppresses the metastatic behavior of malignant rodent tumor lines, and reduced nm23 expression correlates with increased likelihood of lymph node metastases in human breast cancers. More recent data have demonstrated the existence of two human nm23 gene homologues, n...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JNCI : Journal of the National Cancer Institute 1993-01, Vol.85 (2), p.147-152
Hauptverfasser: Myeroff, Lois L., Markowitz, Sanford D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 152
container_issue 2
container_start_page 147
container_title JNCI : Journal of the National Cancer Institute
container_volume 85
creator Myeroff, Lois L.
Markowitz, Sanford D.
description Background The murine nm23 gene suppresses the metastatic behavior of malignant rodent tumor lines, and reduced nm23 expression correlates with increased likelihood of lymph node metastases in human breast cancers. More recent data have demonstrated the existence of two human nm23 gene homologues, nm23-H1 and nm23-H2, and have shown that deletion of nm23-H1 alleles occurs in some colon carcinomas associated with poor prognosis. These findings suggest that nm23-H1 encodes for suppression of colon carcinoma metastasis. In contrast, we have previously reported that total nm23 messenger RNA (mRNA) expression is increased to similar levels in colon tumors of both high and low metastatic potential. Purpose This study was designed to reconcile our previous findings with the recent report of nm23-H1 allelic deletion in human colon cancers associated with poor prognosis. Our purpose was to examine human colon cancers for in-activation of two candidate metastasis suppressor genes, nm23-H1 and nm23-H2, either by mutation or by loss of gene transcription. Methods We used ribonuclease protection assays to analyze human colon tumors for the level of nm23-H1 (43 samples) and nm23-H2 (41 samples) transcript (mRNA) expression and the presence of mutations that could inactivate potential suppressor function. Results We detected only wild-type nm23-H1 and nm23-H2 mRNA. Expression of nm23-H1 mRNA increased in 33 of 41 colon tumors, and expression of nm23-H2 mRNA was elevated in 28 of 41 colon tumors relative to that in matched normal mucosa. Increases in these mRNA levels were similar in tumors of both low and high metastatic potential. Conclusions These results suggest that, despite correlation of nm23-H1 allelic deletions with colon cancers associated with poor prognosis, nm23-H1 and nm23-H2 alleles do not directly mediate metastasis suppression in colon carcinoma. Our results leave unexplained the observation that nm23-H1 allelic deletion correlates with metastatic potential of colon carcinomas. Implications These findings also contrast with the demonstration of nm23 metastasis suppressor activity in murine melanoma and with the correlation of loss of nm23 expression in breast cancer with poor prognosis. It may be that metastasis suppression by the nm23 gene is a tissue-specific phenomenon. [J Natl Cancer Inst 85:147–152, 1993]
doi_str_mv 10.1093/jnci/85.2.147
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75535797</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>75535797</sourcerecordid><originalsourceid>FETCH-LOGICAL-c411t-87a0eb25855ef648fb2dbde57822fde98bfb3ef3a96e4748b5cbbf228850ad603</originalsourceid><addsrcrecordid>eNpdkV1rFDEYhYModa1eeikEEe9mm89J5nKZtm5hqyIVxJuQZJI660yyJjNY_4E_22y7rmBuEt7znPMGDgAvMVpi1NCzbbD9meRLssRMPAILzGpUEYz4Y7BAiIhKSsGegmc5b1E5DWEn4EQyLCliC_D7KtjkdHYdDCOh1RpDHf6-Cbx2Obtw6xL89H4FL-52qQz6GO6hlSmadTB6eD1PeirzDPsA2zgUotXJ9iGOOu-BTfx571n3t99K6qTz3mDhxzi5MPV6eA6eeD1k9-Jwn4LPlxc37brafHh31a42lWUYT5UUGjlDuOTc-ZpJb0hnOseFJMR3rpHGG-o81U3tmGDScGuMJ0RKjnRXI3oK3j7k7lL8Mbs8qbHP1g2DDi7OWQnOKReNKODr_8BtnFMof1OE8ppyRliBqgfIpphzcl7tUj_q9EthpPb1qH09SnJFVKmn8K8OobMZXXekD30U_c1B19nqwSdd7PmIMUF4XdN_a_s8ubujrNN3VQsquFp_-arOzzG9vGmZovQPuz6mYQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>235635424</pqid></control><display><type>article</type><title>Increased nm23-H1 and nm23-H2 Messenger RNA Expression and Absence of Mutations in Colon Carcinomas of Low and High Metastatic Potential</title><source>MEDLINE</source><source>Oxford University Press Journals Digital Archive Legacy</source><creator>Myeroff, Lois L. ; Markowitz, Sanford D.</creator><creatorcontrib>Myeroff, Lois L. ; Markowitz, Sanford D.</creatorcontrib><description>Background The murine nm23 gene suppresses the metastatic behavior of malignant rodent tumor lines, and reduced nm23 expression correlates with increased likelihood of lymph node metastases in human breast cancers. More recent data have demonstrated the existence of two human nm23 gene homologues, nm23-H1 and nm23-H2, and have shown that deletion of nm23-H1 alleles occurs in some colon carcinomas associated with poor prognosis. These findings suggest that nm23-H1 encodes for suppression of colon carcinoma metastasis. In contrast, we have previously reported that total nm23 messenger RNA (mRNA) expression is increased to similar levels in colon tumors of both high and low metastatic potential. Purpose This study was designed to reconcile our previous findings with the recent report of nm23-H1 allelic deletion in human colon cancers associated with poor prognosis. Our purpose was to examine human colon cancers for in-activation of two candidate metastasis suppressor genes, nm23-H1 and nm23-H2, either by mutation or by loss of gene transcription. Methods We used ribonuclease protection assays to analyze human colon tumors for the level of nm23-H1 (43 samples) and nm23-H2 (41 samples) transcript (mRNA) expression and the presence of mutations that could inactivate potential suppressor function. Results We detected only wild-type nm23-H1 and nm23-H2 mRNA. Expression of nm23-H1 mRNA increased in 33 of 41 colon tumors, and expression of nm23-H2 mRNA was elevated in 28 of 41 colon tumors relative to that in matched normal mucosa. Increases in these mRNA levels were similar in tumors of both low and high metastatic potential. Conclusions These results suggest that, despite correlation of nm23-H1 allelic deletions with colon cancers associated with poor prognosis, nm23-H1 and nm23-H2 alleles do not directly mediate metastasis suppression in colon carcinoma. Our results leave unexplained the observation that nm23-H1 allelic deletion correlates with metastatic potential of colon carcinomas. Implications These findings also contrast with the demonstration of nm23 metastasis suppressor activity in murine melanoma and with the correlation of loss of nm23 expression in breast cancer with poor prognosis. It may be that metastasis suppression by the nm23 gene is a tissue-specific phenomenon. [J Natl Cancer Inst 85:147–152, 1993]</description><identifier>ISSN: 0027-8874</identifier><identifier>EISSN: 1460-2105</identifier><identifier>DOI: 10.1093/jnci/85.2.147</identifier><identifier>PMID: 8418304</identifier><identifier>CODEN: JNCIEQ</identifier><language>eng</language><publisher>Cary, NC: Oxford University Press</publisher><subject>Alleles ; Animals ; Autoradiography ; Biological and medical sciences ; Cloning, Molecular ; Colectomy ; Colonic Neoplasms - genetics ; Colonic Neoplasms - pathology ; Colonic Neoplasms - surgery ; Colorectal cancer ; Electrophoresis, Polyacrylamide Gel ; Gastroenterology. Liver. Pancreas. Abdomen ; Gene Deletion ; Gene Expression ; Genes ; Genes, Tumor Suppressor ; Humans ; Medical research ; Medical sciences ; Mice ; Mutation ; Neoplasm Metastasis - genetics ; Prognosis ; Restriction Mapping ; Ribonucleic acid ; RNA ; RNA, Messenger - biosynthesis ; RNA, Messenger - genetics ; RNA, Messenger - isolation &amp; purification ; RNA, Neoplasm - biosynthesis ; RNA, Neoplasm - genetics ; RNA, Neoplasm - isolation &amp; purification ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus ; Transcription, Genetic ; Tumors</subject><ispartof>JNCI : Journal of the National Cancer Institute, 1993-01, Vol.85 (2), p.147-152</ispartof><rights>1993 INIST-CNRS</rights><rights>Copyright Oxford University Press(England) Jan 20, 1993</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c411t-87a0eb25855ef648fb2dbde57822fde98bfb3ef3a96e4748b5cbbf228850ad603</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4725663$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8418304$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Myeroff, Lois L.</creatorcontrib><creatorcontrib>Markowitz, Sanford D.</creatorcontrib><title>Increased nm23-H1 and nm23-H2 Messenger RNA Expression and Absence of Mutations in Colon Carcinomas of Low and High Metastatic Potential</title><title>JNCI : Journal of the National Cancer Institute</title><addtitle>J Natl Cancer Inst</addtitle><description>Background The murine nm23 gene suppresses the metastatic behavior of malignant rodent tumor lines, and reduced nm23 expression correlates with increased likelihood of lymph node metastases in human breast cancers. More recent data have demonstrated the existence of two human nm23 gene homologues, nm23-H1 and nm23-H2, and have shown that deletion of nm23-H1 alleles occurs in some colon carcinomas associated with poor prognosis. These findings suggest that nm23-H1 encodes for suppression of colon carcinoma metastasis. In contrast, we have previously reported that total nm23 messenger RNA (mRNA) expression is increased to similar levels in colon tumors of both high and low metastatic potential. Purpose This study was designed to reconcile our previous findings with the recent report of nm23-H1 allelic deletion in human colon cancers associated with poor prognosis. Our purpose was to examine human colon cancers for in-activation of two candidate metastasis suppressor genes, nm23-H1 and nm23-H2, either by mutation or by loss of gene transcription. Methods We used ribonuclease protection assays to analyze human colon tumors for the level of nm23-H1 (43 samples) and nm23-H2 (41 samples) transcript (mRNA) expression and the presence of mutations that could inactivate potential suppressor function. Results We detected only wild-type nm23-H1 and nm23-H2 mRNA. Expression of nm23-H1 mRNA increased in 33 of 41 colon tumors, and expression of nm23-H2 mRNA was elevated in 28 of 41 colon tumors relative to that in matched normal mucosa. Increases in these mRNA levels were similar in tumors of both low and high metastatic potential. Conclusions These results suggest that, despite correlation of nm23-H1 allelic deletions with colon cancers associated with poor prognosis, nm23-H1 and nm23-H2 alleles do not directly mediate metastasis suppression in colon carcinoma. Our results leave unexplained the observation that nm23-H1 allelic deletion correlates with metastatic potential of colon carcinomas. Implications These findings also contrast with the demonstration of nm23 metastasis suppressor activity in murine melanoma and with the correlation of loss of nm23 expression in breast cancer with poor prognosis. It may be that metastasis suppression by the nm23 gene is a tissue-specific phenomenon. [J Natl Cancer Inst 85:147–152, 1993]</description><subject>Alleles</subject><subject>Animals</subject><subject>Autoradiography</subject><subject>Biological and medical sciences</subject><subject>Cloning, Molecular</subject><subject>Colectomy</subject><subject>Colonic Neoplasms - genetics</subject><subject>Colonic Neoplasms - pathology</subject><subject>Colonic Neoplasms - surgery</subject><subject>Colorectal cancer</subject><subject>Electrophoresis, Polyacrylamide Gel</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Gene Deletion</subject><subject>Gene Expression</subject><subject>Genes</subject><subject>Genes, Tumor Suppressor</subject><subject>Humans</subject><subject>Medical research</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mutation</subject><subject>Neoplasm Metastasis - genetics</subject><subject>Prognosis</subject><subject>Restriction Mapping</subject><subject>Ribonucleic acid</subject><subject>RNA</subject><subject>RNA, Messenger - biosynthesis</subject><subject>RNA, Messenger - genetics</subject><subject>RNA, Messenger - isolation &amp; purification</subject><subject>RNA, Neoplasm - biosynthesis</subject><subject>RNA, Neoplasm - genetics</subject><subject>RNA, Neoplasm - isolation &amp; purification</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><subject>Transcription, Genetic</subject><subject>Tumors</subject><issn>0027-8874</issn><issn>1460-2105</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkV1rFDEYhYModa1eeikEEe9mm89J5nKZtm5hqyIVxJuQZJI660yyJjNY_4E_22y7rmBuEt7znPMGDgAvMVpi1NCzbbD9meRLssRMPAILzGpUEYz4Y7BAiIhKSsGegmc5b1E5DWEn4EQyLCliC_D7KtjkdHYdDCOh1RpDHf6-Cbx2Obtw6xL89H4FL-52qQz6GO6hlSmadTB6eD1PeirzDPsA2zgUotXJ9iGOOu-BTfx571n3t99K6qTz3mDhxzi5MPV6eA6eeD1k9-Jwn4LPlxc37brafHh31a42lWUYT5UUGjlDuOTc-ZpJb0hnOseFJMR3rpHGG-o81U3tmGDScGuMJ0RKjnRXI3oK3j7k7lL8Mbs8qbHP1g2DDi7OWQnOKReNKODr_8BtnFMof1OE8ppyRliBqgfIpphzcl7tUj_q9EthpPb1qH09SnJFVKmn8K8OobMZXXekD30U_c1B19nqwSdd7PmIMUF4XdN_a_s8ubujrNN3VQsquFp_-arOzzG9vGmZovQPuz6mYQ</recordid><startdate>19930120</startdate><enddate>19930120</enddate><creator>Myeroff, Lois L.</creator><creator>Markowitz, Sanford D.</creator><general>Oxford University Press</general><general>Superintendent of Documents</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>19930120</creationdate><title>Increased nm23-H1 and nm23-H2 Messenger RNA Expression and Absence of Mutations in Colon Carcinomas of Low and High Metastatic Potential</title><author>Myeroff, Lois L. ; Markowitz, Sanford D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c411t-87a0eb25855ef648fb2dbde57822fde98bfb3ef3a96e4748b5cbbf228850ad603</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Alleles</topic><topic>Animals</topic><topic>Autoradiography</topic><topic>Biological and medical sciences</topic><topic>Cloning, Molecular</topic><topic>Colectomy</topic><topic>Colonic Neoplasms - genetics</topic><topic>Colonic Neoplasms - pathology</topic><topic>Colonic Neoplasms - surgery</topic><topic>Colorectal cancer</topic><topic>Electrophoresis, Polyacrylamide Gel</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Gene Deletion</topic><topic>Gene Expression</topic><topic>Genes</topic><topic>Genes, Tumor Suppressor</topic><topic>Humans</topic><topic>Medical research</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mutation</topic><topic>Neoplasm Metastasis - genetics</topic><topic>Prognosis</topic><topic>Restriction Mapping</topic><topic>Ribonucleic acid</topic><topic>RNA</topic><topic>RNA, Messenger - biosynthesis</topic><topic>RNA, Messenger - genetics</topic><topic>RNA, Messenger - isolation &amp; purification</topic><topic>RNA, Neoplasm - biosynthesis</topic><topic>RNA, Neoplasm - genetics</topic><topic>RNA, Neoplasm - isolation &amp; purification</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><topic>Transcription, Genetic</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Myeroff, Lois L.</creatorcontrib><creatorcontrib>Markowitz, Sanford D.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>JNCI : Journal of the National Cancer Institute</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Myeroff, Lois L.</au><au>Markowitz, Sanford D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increased nm23-H1 and nm23-H2 Messenger RNA Expression and Absence of Mutations in Colon Carcinomas of Low and High Metastatic Potential</atitle><jtitle>JNCI : Journal of the National Cancer Institute</jtitle><addtitle>J Natl Cancer Inst</addtitle><date>1993-01-20</date><risdate>1993</risdate><volume>85</volume><issue>2</issue><spage>147</spage><epage>152</epage><pages>147-152</pages><issn>0027-8874</issn><eissn>1460-2105</eissn><coden>JNCIEQ</coden><abstract>Background The murine nm23 gene suppresses the metastatic behavior of malignant rodent tumor lines, and reduced nm23 expression correlates with increased likelihood of lymph node metastases in human breast cancers. More recent data have demonstrated the existence of two human nm23 gene homologues, nm23-H1 and nm23-H2, and have shown that deletion of nm23-H1 alleles occurs in some colon carcinomas associated with poor prognosis. These findings suggest that nm23-H1 encodes for suppression of colon carcinoma metastasis. In contrast, we have previously reported that total nm23 messenger RNA (mRNA) expression is increased to similar levels in colon tumors of both high and low metastatic potential. Purpose This study was designed to reconcile our previous findings with the recent report of nm23-H1 allelic deletion in human colon cancers associated with poor prognosis. Our purpose was to examine human colon cancers for in-activation of two candidate metastasis suppressor genes, nm23-H1 and nm23-H2, either by mutation or by loss of gene transcription. Methods We used ribonuclease protection assays to analyze human colon tumors for the level of nm23-H1 (43 samples) and nm23-H2 (41 samples) transcript (mRNA) expression and the presence of mutations that could inactivate potential suppressor function. Results We detected only wild-type nm23-H1 and nm23-H2 mRNA. Expression of nm23-H1 mRNA increased in 33 of 41 colon tumors, and expression of nm23-H2 mRNA was elevated in 28 of 41 colon tumors relative to that in matched normal mucosa. Increases in these mRNA levels were similar in tumors of both low and high metastatic potential. Conclusions These results suggest that, despite correlation of nm23-H1 allelic deletions with colon cancers associated with poor prognosis, nm23-H1 and nm23-H2 alleles do not directly mediate metastasis suppression in colon carcinoma. Our results leave unexplained the observation that nm23-H1 allelic deletion correlates with metastatic potential of colon carcinomas. Implications These findings also contrast with the demonstration of nm23 metastasis suppressor activity in murine melanoma and with the correlation of loss of nm23 expression in breast cancer with poor prognosis. It may be that metastasis suppression by the nm23 gene is a tissue-specific phenomenon. [J Natl Cancer Inst 85:147–152, 1993]</abstract><cop>Cary, NC</cop><pub>Oxford University Press</pub><pmid>8418304</pmid><doi>10.1093/jnci/85.2.147</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0027-8874
ispartof JNCI : Journal of the National Cancer Institute, 1993-01, Vol.85 (2), p.147-152
issn 0027-8874
1460-2105
language eng
recordid cdi_proquest_miscellaneous_75535797
source MEDLINE; Oxford University Press Journals Digital Archive Legacy
subjects Alleles
Animals
Autoradiography
Biological and medical sciences
Cloning, Molecular
Colectomy
Colonic Neoplasms - genetics
Colonic Neoplasms - pathology
Colonic Neoplasms - surgery
Colorectal cancer
Electrophoresis, Polyacrylamide Gel
Gastroenterology. Liver. Pancreas. Abdomen
Gene Deletion
Gene Expression
Genes
Genes, Tumor Suppressor
Humans
Medical research
Medical sciences
Mice
Mutation
Neoplasm Metastasis - genetics
Prognosis
Restriction Mapping
Ribonucleic acid
RNA
RNA, Messenger - biosynthesis
RNA, Messenger - genetics
RNA, Messenger - isolation & purification
RNA, Neoplasm - biosynthesis
RNA, Neoplasm - genetics
RNA, Neoplasm - isolation & purification
Stomach. Duodenum. Small intestine. Colon. Rectum. Anus
Transcription, Genetic
Tumors
title Increased nm23-H1 and nm23-H2 Messenger RNA Expression and Absence of Mutations in Colon Carcinomas of Low and High Metastatic Potential
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T05%3A16%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increased%20nm23-H1%20and%20nm23-H2%20Messenger%20RNA%20Expression%20and%20Absence%20of%20Mutations%20in%20Colon%20Carcinomas%20of%20Low%20and%20High%20Metastatic%20Potential&rft.jtitle=JNCI%20:%20Journal%20of%20the%20National%20Cancer%20Institute&rft.au=Myeroff,%20Lois%20L.&rft.date=1993-01-20&rft.volume=85&rft.issue=2&rft.spage=147&rft.epage=152&rft.pages=147-152&rft.issn=0027-8874&rft.eissn=1460-2105&rft.coden=JNCIEQ&rft_id=info:doi/10.1093/jnci/85.2.147&rft_dat=%3Cproquest_cross%3E75535797%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=235635424&rft_id=info:pmid/8418304&rfr_iscdi=true